Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Gene-expression Analysis Identifies Specific Patterns of Dysregulated Molecular Pathways and Genetic Subgroups of Human Hepatocellular CarcinomaHass, Holger G ; Vogel, Ulrich ; Scheurlen, Michael ; Jobst, JürgenAnticancer research, 2016-10, Vol.36 (10), p.5087-5095 [Peer Reviewed Journal]GreeceFull text available |
2 |
Material Type: Article
|
![]() |
Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study GroupMOOSMANN, Nicolas ; FISCHER VON WEIKERSTHAL, Ludwig ; SCHULZE, Mathias ; ABENHARDT, Wolfgang ; PUCHTLER, Gerhard ; KAPPAUF, Herbert ; MITTERMÜLLER, Johann ; HABERL, Christopher ; SCHALHORN, Andreas ; JUNG, Andreas ; STINTZING, Sebastian ; HEINEMANN, Volker ; VEHLING-KAISER, Ursula ; STAUCH, Martina ; HASS, Holger G ; DIETZFELBINGER, Herrmann ; ORUZIO, Daniel ; KLEIN, Stefan ; ZELLMANN, Klaus ; DECKER, ThomasJournal of clinical oncology, 2011-03, Vol.29 (8), p.1050-1058 [Peer Reviewed Journal]Alexandria, VA: American Society of Clinical OncologyFull text available |
3 |
Material Type: Article
|
![]() |
Subclassification and Detection of New Markers for the Discrimination of Primary Liver Tumors by Gene Expression Analysis Using Oligonucleotide ArraysHass, Holger G ; Vogel, Ulrich ; Scheurlen, Michael ; Jobst, JürgenGut and Liver, 2018, 12(3), , pp.306-315 [Peer Reviewed Journal]Korea (South): Editorial Office of Gut and LiverFull text available |
4 |
Material Type: Article
|
![]() |
Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trialNEHLS, O ; OETTLE, H ; GREGOR, M ; KLUMP, B ; HARTMANN, J. T ; HOFHEINZ, R.-D ; HASS, H. G ; HORGER, M. S ; KOPPENHÖFER, U ; HOCHHAUS, A ; STIELER, J ; TROJAN, JBritish journal of cancer, 2008-01, Vol.98 (2), p.309-315 [Peer Reviewed Journal]Basingstoke: Nature Publishing GroupFull text available |
5 |
Material Type: Article
|
![]() |
Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAXNEHLS, O ; OKECH, T ; HARTMANN, J. T ; PORSCHEN, R ; GREGOR, M ; KLUMP, B ; HSIEH, C.-J ; ENZINGER, T ; SARBIA, M ; BORCHARD, F ; GRUENAGEL, H.-H ; GACO, V ; HASS, H. G ; ARKENAU, H. TBritish journal of cancer, 2007-05, Vol.96 (9), p.1409-1418 [Peer Reviewed Journal]Basingstoke: Nature Publishing GroupFull text available |
6 |
Material Type: Article
|
![]() |
Rapid HBV DNA decrease (week 12) is an important prognostic factor for first-line treatment with adefovir dipivoxil for chronic hepatitis BHass, Holger G ; Bock, Thomas ; Nehls, Oliver ; Kaiser, StephanJournal of gastroenterology, 2009-08, Vol.44 (8), p.871-877 [Peer Reviewed Journal]Japan: Japan : Springer JapanFull text available |
7 |
Material Type: Article
|
![]() |
Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trialvon Einem, J. C. ; Heinemann, V. ; von Weikersthal, L. Fischer ; Vehling-Kaiser, U. ; Stauch, M. ; Hass, H. G. ; Decker, T. ; Klein, S. ; Held, S. ; Jung, A. ; Kirchner, T. ; Haas, M. ; Holch, J. ; Michl, M. ; Aubele, P. ; Boeck, S. ; Schulz, C. ; Giessen, C. ; Stintzing, S. ; Modest, D. P.Journal of cancer research and clinical oncology, 2014-09, Vol.140 (9), p.1607-1614 [Peer Reviewed Journal]Berlin/Heidelberg: Springer Berlin HeidelbergFull text available |
8 |
Material Type: Article
|
![]() |
Long-Term Treatment of Advanced Hepatocellular Carcinoma with the Tyrosine Kinase Inhibitor Erlotinib (Tarceva®) – A Case ReportHass, H G ; Denzlinger, CZeitschrift für Gastroenterologie, 2009-01, Vol.47 (1), p.27-29 [Peer Reviewed Journal]GermanyFull text available |
9 |
Material Type: Article
|
![]() |
Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trialNehls, O ; Klump, B ; Arkenau, H T ; Hass, H G ; Greschniok, A ; Gregor, M ; Porschen, RBritish journal of cancer, 2002-09, Vol.87 (7), p.702-704 [Peer Reviewed Journal]England: Nature Publishing GroupFull text available |
10 |
Material Type: Article
|
![]() |
DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC) – Potential implications for clinical management and treatment decisionsHass, Holger G ; Schmidt, Andreas ; Nehls, Oliver ; Kaiser, StephanOral oncology, 2008-01, Vol.44 (1), p.78-85 [Peer Reviewed Journal]Oxford: Elsevier LtdFull text available |